首页> 美国卫生研究院文献>Journal of Clinical Medicine >Integrative Biology of Diabetic Retinal Disease: Lessons from Diabetic Kidney Disease
【2h】

Integrative Biology of Diabetic Retinal Disease: Lessons from Diabetic Kidney Disease

机译:糖尿病视网膜疾病的综合生物学:糖尿病肾病的课程

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Diabetic retinal disease (DRD) remains the most common cause of vision loss in adults of working age. Progress on the development of new therapies for DRD has been limited by the complexity of the human eye, which constrains the utility of traditional research techniques, including animal and tissue culture models—a problem shared by those in the field of kidney disease research. By contrast, significant progress in the study of diabetic kidney disease (DKD) has resulted from the successful employment of systems biology approaches. Systems biology is widely used to comprehensively understand complex human diseases through the unbiased integration of genetic, environmental, and phenotypic aspects of the disease with the functional and structural manifestations of the disease. The application of a systems biology approach to DRD may help to clarify the molecular basis of the disease and its progression. Acquiring this type of information might enable the development of personalized treatment approaches, with the goal of discovering new therapies targeted to an individual’s specific DRD pathophysiology and phenotype. Furthermore, recent efforts have revealed shared and distinct pathways and molecular targets of DRD and DKD, highlighting the complex pathophysiology of these diseases and raising the possibility of therapeutics beneficial to both organs. The objective of this review is to survey the current understanding of DRD pathophysiology and to demonstrate the investigative approaches currently applied to DKD that could promote a more thorough understanding of the structure, function, and progression of DRD.
机译:糖尿病视网膜疾病(DRD)仍然是工作年龄成年人视力丧失的最常见原因。 DRD新疗法的发展进展受到人眼的复杂性的限制,这限制了传统研究技术的效用,包括动物和组织文化模型 - 肾病研究领域共享的问题。相比之下,糖尿病肾病(DKD)研究的重大进展是由于系统生物学方法的成功就业。系统生物学广泛用于通过遗传,环境和表型方面与疾病的功能性和结构表现的遗传,环境和表型方面的无偏见整合全面了解复杂的人类疾病。系统生物学方法对DRD的应用可能有助于阐明疾病的分子基础及其进展。获取这种类型的信息可能使个性化治疗方法的发展能够发现针对个人特定的DRD病理生理学和表型的新疗法的目标。此外,最近的努力揭示了DRD和DKD的共同和不同的途径和分子靶点,突出了这些疾病的复杂病理学生理学,并提高了对两个器官有益的治疗方法的可能性。本综述的目的是调查目前对DRD病理生理学的理解,并展示目前适用于DKD的调查方法,可以促进DRD的结构,功能和进展更彻底的了解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号